WINNIPEG, Manitoba--(BUSINESS WIRE)--Cubresa has installed the first BrainPET Insert System at St. Joseph’s Health Care London, in partnership with the hospital’s research institute – Lawson Health Research Institute.
The Cubresa BrainPET is a removeable, high-performing PET scanner, specifically designed for PET/MRI brain imaging.
“We are very excited to receive the world’s first Cubresa BrainPET. By operating inside of our existing 3T MRI, this head-only PET system will enhance the possibilities of brain imaging with superior image resolution,” said Dr. Jonathan Thiessen, Imaging Scientist at Lawson Health Research Institute. “High-resolution PET/MRI will enhance the differential diagnosis of dementia, improve the detection of epileptic foci, and improve our understanding of the aging brain. In collaboration with Cubresa, we look forward to pushing the boundaries of the current technologies and developing new research and clinical applications for the device. The BrainPET will help Lawson and St. Joseph’s to continue to be at the forefront of PET/MRI technology development and clinical research.”
The Cubresa BrainPET is a diagnostic imaging research tool that aids in the detection, localization, and diagnosis of diseases and disorders of the brain, and will enable evaluation of neurological diseases and brain cancers.
“Lawson is the first institute in our Foundational Client Program to have their scanner installed,” said Dr. James Schellenberg, Cubresa’s Founder and CEO. “This is an incredible milestone for our company and an exciting time for brain imaging. We look forward to working with our partners at Lawson over the coming years who are focused on cutting-edge brain research activities.”
Cubresa’s Foundational Client Program is designed for world-leading, innovative brain research institutions who are seeking to enhance their brain-focused research activities with the addition of a novel BrainPET system, enabling simultaneous PET/MR imaging.
About the Cubresa BrainPET Insert System
BrainPET is an investigational PET insert dedicated to the human brain imaging marketplace. It is intended to retrofit into installed 1.5T, 3T and 7T MRI systems, and will be useful for those clinical sites that want the advantages of simultaneous PET/MR imaging. The Cubresa BrainPET Insert System is being developed for the evaluation of neurological diseases and disorders. BrainPET is an investigational device and is not available for commercial sale.
About Cubresa Inc.
Cubresa, based in Winnipeg, Canada, is a world leader in brain imaging and designs and develops preclinical and clinical PET inserts for MRI. Cubresa products are being developed to enable researchers at leading universities, hospitals, and pharmaceutical companies to visualize and measure biochemical processes at the molecular level. www.cubresa.com
About Lawson Health Research Institute: Lawson Health Research Institute is one of Canada’s top hospital-based research institutes, tackling the most pressing challenges in health care. As the research institute of London Health Sciences Centre and St. Joseph’s Health Care London, our innovation happens where care is delivered. Lawson research teams are at the leading-edge of science with the goal of improving health and the delivery of care for patients. Working in partnership with Western University, our researchers are encouraged to pursue their curiosity, collaborate often and share their discoveries widely. Research conducted through Lawson makes a difference in the lives of patients, families and communities around the world. To learn more, visit www.lawsonresearch.ca.
